Shopping Cart 0
Cart Subtotal
AED 0

GlaxoSmithKline Plc - Strategy, SWOT and Corporate Finance Report

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 642

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 1285

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 1927

Details

GlaxoSmithKline Plc-Strategy, SWOT and Corporate Finance Report

Summary

GlaxoSmithKline Plc-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

GlaxoSmithKline plc (GSK or 'the company') is a healthcare company that develops, manufactures and sells vaccines, pharmaceuticals, over-the-counter (OTC) medicines and consumer healthcare products. The company offers medicines for various therapeutic areas, including respiratory, HIV, metabolic, anti-virals, urogenital, central nervous system, immuno-inflammation, cardiovascular, anti-bacterials and dermatology. GSK markets its products under Volibris, Benlysta SCbelimumab, Benlysta, Augmentin, FluLaval, Bexsero, Menveo, Zovirax, Pronamel, Otrivin, Theraflu, Aquafresh, Abreva and Poligrip brand names. The company merchandises and sells these products through pharmacies, hospitals, wholesalers, and physicians worldwide. It has business presence across the UK, the US and Europe. The company is headquartered in Brentford, Middlesex, the UK.

Scope

- Detailed information on GlaxoSmithKline Plc required for business and competitor intelligence needs

- A study of the major internal and external factors affecting GlaxoSmithKline Plc in the form of a SWOT analysis

- An in-depth view of the business model of GlaxoSmithKline Plc including a breakdown and examination of key business segments

- Intelligence on GlaxoSmithKline Plc's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

- News about GlaxoSmithKline Plc, such as business expansion, restructuring, and contract wins

- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of GlaxoSmithKline Plc and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess GlaxoSmithKline Plc as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on GlaxoSmithKline Plc's business structure, strategy and prospects.

READ MORE

Table Of Content

Scope

Table of Contents

Company Snapshot

Table of Contents

GlaxoSmithKline Plc: Company Overview

GlaxoSmithKline Plc: Overview and Key Facts

GlaxoSmithKline Plc: Overview

GlaxoSmithKline Plc: Key Facts

GlaxoSmithKline Plc: Key Employees

GlaxoSmithKline Plc: Key Employee Biographies

GlaxoSmithKline Plc: Major Products and Services

GlaxoSmithKline Plc: Company History

GlaxoSmithKline Plc: Management Statement

GlaxoSmithKline Plc: Locations and Subsidiaries

GlaxoSmithKline Plc: Key Competitors

GlaxoSmithKline Plc: Company Analysis

GlaxoSmithKline Plc: Business Description

GlaxoSmithKline Plc: SWOT Analysis

GlaxoSmithKline Plc: SWOT Overview

GlaxoSmithKline Plc: Strengths

GlaxoSmithKline Plc: Weaknesses

GlaxoSmithKline Plc: Opportunities

GlaxoSmithKline Plc: Threats

GlaxoSmithKline Plc: Corporate Financial Deals Activity

GlaxoSmithKline Plc: Financial Deals Overview

GlaxoSmithKline Plc: Targets and Partners

GlaxoSmithKline Plc: Top Deals 2015-2019YTD*

GlaxoSmithKline Plc: Advisors

GlaxoSmithKline Plc: Top Legal Advisors

GlaxoSmithKline Plc: Top Financial Advisors

GlaxoSmithKline Plc: Mergers and Acquisitions

GlaxoSmithKline Plc: Corporate Venturing

GlaxoSmithKline Plc: Capital Raising

GlaxoSmithKline Plc: Partnership

GlaxoSmithKline Plc: Divestments

GlaxoSmithKline Plc: Recent Developments

GlaxoSmithKline Plc: News and Events Summary

GlaxoSmithKline Plc: Business Expansion

GlaxoSmithKline Plc: Contracts

GlaxoSmithKline Plc: Corporate Governance

GlaxoSmithKline Plc: Financial Deals

GlaxoSmithKline Plc: Market Developments

GlaxoSmithKline Plc: Red Flags/DistressSignals

GlaxoSmithKline Plc: Regulatory and Legal Events

GlaxoSmithKline Plc: Research & Development

GlaxoSmithKline Plc: Strategy and Operations

Appendix

Contact Us

Methodology

About MarketLine


List Of Figure

List of Figures

Figure 1: GlaxoSmithKline Plc: Deal Activity by Deal Type-Volume (TTM*)

Figure 2: GlaxoSmithKline Plc: M&A Activity by Geography (TTM*)

Figure 3: GlaxoSmithKline Plc: Deal Activity by Deal Type-Volume (2015-YTD*2019)

Figure 4: GlaxoSmithKline Plc: M&A Average Deal Size-Value (USD m)

Figure 5: GlaxoSmithKline Plc: M&A Volume and Value Trend (2015-YTD*2019)

Figure 6: GlaxoSmithKline Plc: M&A Activity by Geography (2015-YTD*2019)

Figure 7: GlaxoSmithKline Plc: Corporate Venturing Volume and Value Trend (2015-YTD*2019)

Figure 8: GlaxoSmithKline Plc: Corporate Venturing by Geography (2015-YTD*2019)

Figure 9: GlaxoSmithKline Plc: Capital Raising Volume and Value Trend (2015-YTD*2019)

Figure 10: GlaxoSmithKline Plc: Capital Raising by Deal Type (2015-YTD*2019)

Figure 11: GlaxoSmithKline Plc: Partnership Volume and Value Trend (2015-YTD*2019)

Figure 12: GlaxoSmithKline Plc: Partnership Trend by Deal Type (2015-YTD*2019)

Figure 13: GlaxoSmithKline Plc: Divestments Volume and Value Trend (2015-YTD*2019)

Figure 14: GlaxoSmithKline Plc: Divestments by Geography (2015-YTD*2019)


List Of Table

List of Tables

Table 1: GlaxoSmithKline Plc: Key Facts

Table 2: GlaxoSmithKline Plc: Key Employees

Table 3: GlaxoSmithKline Plc: Company History

Table 4: GlaxoSmithKline Plc: Locations and Subsidiaries

Table 5: GlaxoSmithKline Plc: Key Competitors

Table 6: GlaxoSmithKline Plc: Deal Activity by Deal Type-Volume (TTM*)

Table 7: GlaxoSmithKline Plc: M&A Activity by Geography (TTM*)

Table 8: GlaxoSmithKline Plc: Deal Activity by Deal Type-Volume (2015-YTD*2019)

Table 9: GlaxoSmithKline Plc: M&A Average Deal Size-Value (USD m)

Table 10: GlaxoSmithKline Plc: Targets and Partners

Table 11: GlaxoSmithKline Plc: Top Deals 2015-2019YTD*

Table 12: GlaxoSmithKline Plc: Legal Advisor Ranking by Value (USD m)

Table 13: GlaxoSmithKline Plc: Financial Advisor Ranking by Value (USD m)

Table 14: GlaxoSmithKline Plc: M&A Volume and Value Trend (2015-YTD*2019)

Table 15: GlaxoSmithKline Plc: M&A Activity by Geography (2015-YTD*2019)

Table 16: GlaxoSmithKline Plc: Corporate Venturing Volume and Value Trend (2015-YTD*2019)

Table 17: GlaxoSmithKline Plc: Corporate Venturing by Geography (2015-YTD*2019)

Table 18: GlaxoSmithKline Plc: Capital Raising Volume and Value Trend (2015-YTD*2019)

Table 19: GlaxoSmithKline Plc: Capital Raising by Deal Type (2015-YTD*2019)

Table 20: GlaxoSmithKline Plc: Partnership Volume and Value Trend (2015-YTD*2019)

Table 21: GlaxoSmithKline Plc: Partnership Trend by Deal Type (2015-YTD*2019)

Table 22: GlaxoSmithKline Plc: Divestments Volume and Value Trend (2015-YTD*2019)

Table 23: GlaxoSmithKline Plc: Divestments by Geography (2015-YTD*2019)

Table 24: GlaxoSmithKline Plc: News and Events Summary

Table 25: GlaxoSmithKline Plc: Business Expansion

Table 26: GlaxoSmithKline Plc: Contracts

Table 27: GlaxoSmithKline Plc: Corporate Governance

Table 28: GlaxoSmithKline Plc: Financial Deals

Table 29: GlaxoSmithKline Plc: Market Developments

Table 30: GlaxoSmithKline Plc: Red Flags/DistressSignals

Table 31: GlaxoSmithKline Plc: Regulatory and Legal Events

Table 32: GlaxoSmithKline Plc: Research & Development

Table 33: GlaxoSmithKline Plc: Strategy and Operations

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

GlaxoSmithKline Plc-Strategy, SWOT and Corporate Finance Report

Summary

GlaxoSmithKline Plc-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

GlaxoSmithKline plc (GSK or 'the company') is a healthcare company that develops, manufactures and sells vaccines, pharmaceuticals, over-the-counter (OTC) medicines and consumer healthcare products. The company offers medicines for various therapeutic areas, including respiratory, HIV, metabolic, anti-virals, urogenital, central nervous system, immuno-inflammation, cardiovascular, anti-bacterials and dermatology. GSK markets its products under Volibris, Benlysta SCbelimumab, Benlysta, Augmentin, FluLaval, Bexsero, Menveo, Zovirax, Pronamel, Otrivin, Theraflu, Aquafresh, Abreva and Poligrip brand names. The company merchandises and sells these products through pharmacies, hospitals, wholesalers, and physicians worldwide. It has business presence across the UK, the US and Europe. The company is headquartered in Brentford, Middlesex, the UK.

Scope

- Detailed information on GlaxoSmithKline Plc required for business and competitor intelligence needs

- A study of the major internal and external factors affecting GlaxoSmithKline Plc in the form of a SWOT analysis

- An in-depth view of the business model of GlaxoSmithKline Plc including a breakdown and examination of key business segments

- Intelligence on GlaxoSmithKline Plc's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

- News about GlaxoSmithKline Plc, such as business expansion, restructuring, and contract wins

- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of GlaxoSmithKline Plc and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess GlaxoSmithKline Plc as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on GlaxoSmithKline Plc's business structure, strategy and prospects.

READ MORE

Scope

Table of Contents

Company Snapshot

Table of Contents

GlaxoSmithKline Plc: Company Overview

GlaxoSmithKline Plc: Overview and Key Facts

GlaxoSmithKline Plc: Overview

GlaxoSmithKline Plc: Key Facts

GlaxoSmithKline Plc: Key Employees

GlaxoSmithKline Plc: Key Employee Biographies

GlaxoSmithKline Plc: Major Products and Services

GlaxoSmithKline Plc: Company History

GlaxoSmithKline Plc: Management Statement

GlaxoSmithKline Plc: Locations and Subsidiaries

GlaxoSmithKline Plc: Key Competitors

GlaxoSmithKline Plc: Company Analysis

GlaxoSmithKline Plc: Business Description

GlaxoSmithKline Plc: SWOT Analysis

GlaxoSmithKline Plc: SWOT Overview

GlaxoSmithKline Plc: Strengths

GlaxoSmithKline Plc: Weaknesses

GlaxoSmithKline Plc: Opportunities

GlaxoSmithKline Plc: Threats

GlaxoSmithKline Plc: Corporate Financial Deals Activity

GlaxoSmithKline Plc: Financial Deals Overview

GlaxoSmithKline Plc: Targets and Partners

GlaxoSmithKline Plc: Top Deals 2015-2019YTD*

GlaxoSmithKline Plc: Advisors

GlaxoSmithKline Plc: Top Legal Advisors

GlaxoSmithKline Plc: Top Financial Advisors

GlaxoSmithKline Plc: Mergers and Acquisitions

GlaxoSmithKline Plc: Corporate Venturing

GlaxoSmithKline Plc: Capital Raising

GlaxoSmithKline Plc: Partnership

GlaxoSmithKline Plc: Divestments

GlaxoSmithKline Plc: Recent Developments

GlaxoSmithKline Plc: News and Events Summary

GlaxoSmithKline Plc: Business Expansion

GlaxoSmithKline Plc: Contracts

GlaxoSmithKline Plc: Corporate Governance

GlaxoSmithKline Plc: Financial Deals

GlaxoSmithKline Plc: Market Developments

GlaxoSmithKline Plc: Red Flags/DistressSignals

GlaxoSmithKline Plc: Regulatory and Legal Events

GlaxoSmithKline Plc: Research & Development

GlaxoSmithKline Plc: Strategy and Operations

Appendix

Contact Us

Methodology

About MarketLine


List Of Figure

List of Figures

Figure 1: GlaxoSmithKline Plc: Deal Activity by Deal Type-Volume (TTM*)

Figure 2: GlaxoSmithKline Plc: M&A Activity by Geography (TTM*)

Figure 3: GlaxoSmithKline Plc: Deal Activity by Deal Type-Volume (2015-YTD*2019)

Figure 4: GlaxoSmithKline Plc: M&A Average Deal Size-Value (USD m)

Figure 5: GlaxoSmithKline Plc: M&A Volume and Value Trend (2015-YTD*2019)

Figure 6: GlaxoSmithKline Plc: M&A Activity by Geography (2015-YTD*2019)

Figure 7: GlaxoSmithKline Plc: Corporate Venturing Volume and Value Trend (2015-YTD*2019)

Figure 8: GlaxoSmithKline Plc: Corporate Venturing by Geography (2015-YTD*2019)

Figure 9: GlaxoSmithKline Plc: Capital Raising Volume and Value Trend (2015-YTD*2019)

Figure 10: GlaxoSmithKline Plc: Capital Raising by Deal Type (2015-YTD*2019)

Figure 11: GlaxoSmithKline Plc: Partnership Volume and Value Trend (2015-YTD*2019)

Figure 12: GlaxoSmithKline Plc: Partnership Trend by Deal Type (2015-YTD*2019)

Figure 13: GlaxoSmithKline Plc: Divestments Volume and Value Trend (2015-YTD*2019)

Figure 14: GlaxoSmithKline Plc: Divestments by Geography (2015-YTD*2019)


List Of Table

List of Tables

Table 1: GlaxoSmithKline Plc: Key Facts

Table 2: GlaxoSmithKline Plc: Key Employees

Table 3: GlaxoSmithKline Plc: Company History

Table 4: GlaxoSmithKline Plc: Locations and Subsidiaries

Table 5: GlaxoSmithKline Plc: Key Competitors

Table 6: GlaxoSmithKline Plc: Deal Activity by Deal Type-Volume (TTM*)

Table 7: GlaxoSmithKline Plc: M&A Activity by Geography (TTM*)

Table 8: GlaxoSmithKline Plc: Deal Activity by Deal Type-Volume (2015-YTD*2019)

Table 9: GlaxoSmithKline Plc: M&A Average Deal Size-Value (USD m)

Table 10: GlaxoSmithKline Plc: Targets and Partners

Table 11: GlaxoSmithKline Plc: Top Deals 2015-2019YTD*

Table 12: GlaxoSmithKline Plc: Legal Advisor Ranking by Value (USD m)

Table 13: GlaxoSmithKline Plc: Financial Advisor Ranking by Value (USD m)

Table 14: GlaxoSmithKline Plc: M&A Volume and Value Trend (2015-YTD*2019)

Table 15: GlaxoSmithKline Plc: M&A Activity by Geography (2015-YTD*2019)

Table 16: GlaxoSmithKline Plc: Corporate Venturing Volume and Value Trend (2015-YTD*2019)

Table 17: GlaxoSmithKline Plc: Corporate Venturing by Geography (2015-YTD*2019)

Table 18: GlaxoSmithKline Plc: Capital Raising Volume and Value Trend (2015-YTD*2019)

Table 19: GlaxoSmithKline Plc: Capital Raising by Deal Type (2015-YTD*2019)

Table 20: GlaxoSmithKline Plc: Partnership Volume and Value Trend (2015-YTD*2019)

Table 21: GlaxoSmithKline Plc: Partnership Trend by Deal Type (2015-YTD*2019)

Table 22: GlaxoSmithKline Plc: Divestments Volume and Value Trend (2015-YTD*2019)

Table 23: GlaxoSmithKline Plc: Divestments by Geography (2015-YTD*2019)

Table 24: GlaxoSmithKline Plc: News and Events Summary

Table 25: GlaxoSmithKline Plc: Business Expansion

Table 26: GlaxoSmithKline Plc: Contracts

Table 27: GlaxoSmithKline Plc: Corporate Governance

Table 28: GlaxoSmithKline Plc: Financial Deals

Table 29: GlaxoSmithKline Plc: Market Developments

Table 30: GlaxoSmithKline Plc: Red Flags/DistressSignals

Table 31: GlaxoSmithKline Plc: Regulatory and Legal Events

Table 32: GlaxoSmithKline Plc: Research & Development

Table 33: GlaxoSmithKline Plc: Strategy and Operations

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS